Carlsbad, CA, United States of America

Yi Jin

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 5.4

ph-index = 11

Forward Citations = 664(Granted Patents)


Location History:

  • Montreal, CA (1998 - 2003)
  • Winnipeg, CA (2000 - 2005)
  • Pointe Claire, CA (2007)
  • Carlsbad, CA (US) (2005 - 2024)

Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: The Innovative Mind of Yi Jin: A Pioneer in Modified Oligonucleotides

Introduction: Yi Jin is a prominent inventor based in Carlsbad, California, renowned for his significant contributions to the field of molecular biology. With an impressive portfolio of 23 patents, Jin has made remarkable strides in the development of modified oligonucleotides, which have essential applications in combating viral infections like hepatitis B virus (HBV).

Latest Patents: Among his latest innovations, Yi Jin has focused on the introduction of modified oligonucleotides that include modifications at the 2' and/or 3′ positions, alongside methods for their synthesis and utilization. These advancements present new therapeutic possibilities in the fight against HBV, showcasing Jin’s commitment to addressing critical health challenges through innovative research.

Career Highlights: Yi Jin has successfully collaborated with some esteemed organizations, notably McGill University, where he contributed to leading-edge research that melds academic prowess with practical applications. Furthermore, his tenure at Nitto Denko Corporation has also enriched his experience, allowing him to bridge the gap between theoretical exploration and real-world impact in the biotechnology sector.

Collaborations: Throughout his illustrious career, Yi Jin has worked alongside notable colleagues such as George Just and Zhili Xin. These collaborative efforts reflect a shared commitment to innovation and scientific advancement, exemplifying the collective endeavor to push the boundaries of what's possible in modern biotechnology.

Conclusion: Yi Jin's career is a testament to the power of innovation in the ever-evolving field of biotechnology. With a cumulative number of 23 patents, his work on modified oligonucleotides is setting a precedent for future research and applications. As he continues to explore new frontiers in molecular biology, his contributions are likely to leave a lasting impact on health sciences and biotechnological advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…